Stay updated on Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.

Latest updates to the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4; there are no substantive changes to study details, eligibility criteria, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedLocations section added listing participating sites by state (e.g., Alabama, Arizona, California, District of Columbia, Florida, Illinois, Louisiana, Massachusetts, Michigan, Minnesota, New Jersey, New York, North Carolina, Ohio, Oklahoma, Tennessee, Texas, Virginia, Washington). The page revision updated to v3.3.3.SummaryDifference2%

- Check52 days agoChange DetectedA note clarifying that PubMed publications are automatically filled and may not be about the study; revision: v3.3.2.SummaryDifference0.1%

- Check59 days agoChange DetectedThe government funding notice was removed from the page. It does not affect the study details, eligibility criteria, or participation instructions.SummaryDifference0.3%

- Check73 days agoChange DetectedStudy Details page for NCT02657889 shows no significant changes between screenshots; core information about the TOPACIO trial appears unchanged.SummaryDifference0.3%

- Check102 days agoChange DetectedUpdated version to v3.2.0 and added a government-operation status notice; removed the v3.1.0 reference.SummaryDifference2%

Stay in the know with updates to Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.